Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function (scientific article published on 01 November 1999)

cites work (P2860)

Q55263071	2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Q45059153	2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Q46658026	2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Q58567314	3.0T Contrast-enhanced whole-heart coronary magnetic resonance angiography for simultaneous coronary artery angiography and myocardial viability in chronic myocardial infarction: A single-center preliminary study
Q24651116	32-element receiver-coil array for cardiac imaging
Q47987823	3D late gadolinium enhanced cardiovascular MR with CENTRA-PLUS profile/view ordering: Feasibility of right ventricular myocardial damage assessment using a swine animal model
Q47310796	3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography
Q39772870	A Method to Standardize Quantification of Left Atrial Scar From Delayed-Enhancement MR Images
Q35764648	A Novel Method for Quantifying Smooth Regional Variations in Myocardial Contractility Within an Infarcted Human Left Ventricle Based on Delay-Enhanced Magnetic Resonance Imaging
Q81571093	A new LMNA mutation causing limb girdle muscular dystrophy 1B
Q31090542	A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
Q51801246	A simple MR algorithm for estimation of myocardial salvage following acute ST segment elevation myocardial infarction.
Q38724882	A systematic comparison of cardiovascular magnetic resonance and high resolution histological fibrosis quantification in a chronic porcine infarct model
Q36186641	Accelerated late gadolinium enhancement cardiac MR imaging with isotropic spatial resolution using compressed sensing: initial experience
Q26746199	Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging?
Q34066763	Acute infarct selective MRI contrast agent.
Q37162585	Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI.
Q30434105	Advances in Cardiovascular MRI for Diagnostics: Applications in Coronary Artery Disease and Cardiomyopathies
Q38304851	Advances in cardiac magnetic resonance imaging of congenital heart disease
Q36971128	Advances in clinical applications of cardiovascular magnetic resonance imaging
Q38052020	Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.
Q38665321	Adverse Remodeling and Reverse Remodeling After Myocardial Infarction
Q38911760	Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.
Q46218240	Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability
Q33526075	Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart disease
Q36174413	Alström syndrome: cardiac magnetic resonance findings
Q30425918	American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association
Q36814844	An overview on the advances in cardiovascular interventional MR imaging
Q46459882	Analysis of microvascularity after reperfused acute myocardial infarction using the maximum slope method of contrast-enhanced magnetic resonance imaging
Q83396263	Anatomical and functional evaluation of the myocardium in patients with acute coronary syndrome (NSTEMI) using MR imaging
Q58803993	Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
Q89462488	Aortic Stiffness and Infarct Healing in Survivors of Acute ST-Segment-Elevation Myocardial Infarction
Q37322418	Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction
Q30464771	Applications of cardiac magnetic resonance in electrophysiology
Q33521778	Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model
Q42101708	Arrhythmias after tetralogy of fallot repair
Q81176200	Arrhythmogenic right ventricular dysplasia/cardiomyopathy
Q36676196	Artifact suppression in imaging of myocardial infarction using B1-weighted phased-array combined phase-sensitive inversion recovery
Q36423675	Assessing right ventricular function: the role of echocardiography and complementary technologies.
Q38221966	Assessment and impact of cardiac fibrosis on atrial fibrillation
Q34561285	Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology
Q86103498	Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols
Q28387402	Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance
Q34846884	Assessment of myocardial fibrosis with cardiovascular magnetic resonance
Q43046059	Assessment of myocardial infarction in mice by late gadolinium enhancement MR imaging using an inversion recovery pulse sequence at 9.4T.
Q44830969	Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium
Q43282409	Assessment of myocardial ischemia and viability using cardiac magnetic resonance
Q53590962	Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results.
Q36180655	Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation
Q30361261	Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques.
Q36633655	Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation
Q34051551	Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study
Q57457080	Association of myocardial fibrosis and cardiovascular events: the multi-ethnic study of atherosclerosis
Q57740179	Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study
Q33862943	Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI
Q84123786	Atrial fibrillation: Predicting the efficacy of pulmonary vein isolation with CMR
Q35026290	Automated quantification of myocardial salvage in a rat model of ischemia-reperfusion injury using 3D high-resolution magnetic resonance imaging (MRI).
Q38447384	Automated scar quantification by CMR: a step in the right direction.
Q35946709	Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.
Q82852097	Beneficial effect of delayed reperfusion in ST elevation myocardial infarction despite transmural necrosis documented in cardiac magnetic resonance imaging
Q40223281	Bifunctional staining for ex vivo determination of area at risk in rabbits with reperfused myocardial infarction
Q37790602	CMR for characterization of the myocardium in acute coronary syndromes
Q37634312	CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy
Q42721726	Can we still rely on the ECG for detecting past myocardial injury?
Q37061992	Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies
Q57680940	Cardiac 99mTc sestamibi SPECT and 18F FDG PET as viability markers in takotsubo cardiomyopathy
Q42288873	Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study
Q30248624	Cardiac Imaging in Heart Failure with Comorbidities
Q37195695	Cardiac MR for the assessment of myocardial viability.
Q35083364	Cardiac MR imaging
Q82057893	Cardiac MRI in the management of congenital heart disease in children, adolescents, and young adults
Q37264368	Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention
Q38263089	Cardiac MRI: a central prognostic tool in myocardial fibrosis
Q26801712	Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy
Q50100398	Cardiac Magnetic Resonance for Lesion Assessment in the Electrophysiology Laboratory
Q85181634	Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
Q30558233	Cardiac imaging techniques for physicians: late enhancement
Q36332864	Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction
Q34382504	Cardiac imaging using clinical 1.5 t MRI scanners in a murine ischemia/reperfusion model
Q33722728	Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: a histological validation study
Q36247177	Cardiac magnetic resonance at high field: promises and problems.
Q30432349	Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications
Q39255836	Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!
Q30441721	Cardiac magnetic resonance imaging in patients with coronary disease
Q36137976	Cardiac magnetic resonance imaging in small rodents using clinical 1.5 T and 3.0 T scanners
Q30475223	Cardiac magnetic resonance imaging in stable ischaemic heart disease
Q50027498	Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism
Q35240779	Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction
Q80488538	Cardiac magnetic resonance imaging: an essential diagnostic aid in suspected myocardial re-infarction in a 40 year old woman
Q37776517	Cardiac magnetic resonance imaging: current status and future directions
Q35584601	Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease
Q38143060	Cardiac magnetic resonance in adults with congenital heart disease.
Q38336304	Cardiac magnetic resonance in clinical cardiology
Q36498834	Cardiac magnetic resonance in myocardial disease
Q53500764	Cardiac magnetic resonance versus SPECT: are all noninfarct myocardial regions created equal?
Q30497515	Cardiac resynchronization therapy guided by cardiovascular magnetic resonance
Q37417607	Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging
Q30480746	Cardiovascular MR and CT in congenital heart disease.
Q36257372	Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction
Q30484286	Cardiovascular MRI for detection of myocardial viability and ischaemia
Q39738574	Cardiovascular MRI in Detection and Measurement of Aortic Atheroma in Stroke/TIA patients
Q35124348	Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints
Q88523483	Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions
Q93088682	Cardiovascular Magnetic Resonance-Based Three-Dimensional Structural Modeling and Heterogeneous Tissue Channel Detection in Ventricular Arrhythmia
Q57979130	Cardiovascular Multimodality Imaging: It is Time to Get on Board! A "Società Italiana di Ecocardiografia e CardioVascular Imaging" Statement
Q42696123	Cardiovascular PET/MR: We need evidence, not hype
Q42650973	Cardiovascular imaging in clinical practice: what does late gadolinium enhance?
Q26779676	Cardiovascular imaging: what have we learned from animal models?
Q35854372	Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction
Q36969090	Cardiovascular magnetic resonance for the clinical cardiologist
Q39176820	Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction
Q26860052	Cardiovascular magnetic resonance imaging for assessment of cardiac thrombus
Q37844431	Cardiovascular magnetic resonance imaging in experimental models
Q30432814	Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies
Q34241060	Cardiovascular magnetic resonance imaging of scar development following pulmonary vein isolation: a prospective study
Q40513466	Cardiovascular magnetic resonance imaging: current applications and future directions
Q37848215	Cardiovascular magnetic resonance in heart failure
Q24654343	Cardiovascular magnetic resonance in myocarditis: A JACC White Paper
Q30466693	Cardiovascular magnetic resonance in systemic hypertension
Q30480205	Cardiovascular magnetic resonance in the evaluation of heart failure
Q52950128	Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage.
Q37353258	Cardiovascular magnetic resonance of cardiomyopathies
Q26852691	Cardiovascular magnetic resonance physics for clinicians: Part II.
Q30430740	Cardiovascular magnetic resonance: applications in daily practice
Q30437076	Cardiovascular magnetic resonance: structure, function, perfusion, and viability
Q38222227	Catheter ablation guided by real-time MRI.
Q37187645	Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction
Q28607072	Challenges of cardiac image analysis in large-scale population-based studies
Q40147991	Changes in remote myocardial tissue after acute myocardial infarction and its relation to cardiac remodeling: A CMR T1 mapping study.
Q36625788	Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function
Q47179173	Characterization of Gadolinium Contrast Enhancement of Radiofrequency Ablation Lesions in Predicting Edema and Chronic Lesion Size
Q36700588	Characterization of myocardial viability using MR and CT imaging
Q41845897	Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging
Q83178066	Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction
Q30439253	Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice
Q83824784	Chronic mitral regurgitation detected on cardiac MDCT: differentiation between functional and valvular aetiologies
Q33524903	Chronic non-transmural infarction has a delayed recovery of function following revascularization
Q46827514	Chronic pseudoaneurysm of the left ventricle
Q80368846	Cine and tagged magnetic resonance imaging in short-term stunned versus necrotic myocardium
Q37648304	Classic images in cardiac magnetic resonance imaging: a case-based atlas highlighting current applications of cardiac magnetic resonance imaging
Q37805112	Clinical Relevance of Hibernating Myocardium in Ischemic Left Ventricular Dysfunction
Q35986796	Clinical assessment of myocardial hibernation
Q34166827	Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging
Q89565666	Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts
Q46302186	Clinical performance of high-resolution late gadolinium enhancement imaging with compressed sensing.
Q40188045	Clinical predictors for the manifestation of late gadolinium enhancement after acute myocardial infarction
Q46575009	Clinical safety of cardiac magnetic resonance imaging at 3 T early after stent placement for acute myocardial infarction
Q26999424	Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy
Q92228629	Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation
Q82250010	Closed-chest animal model of chronic coronary artery stenosis. Assessment with magnetic resonance imaging
Q46355205	Colors of Myocardial Infarction: Can They Predict the Future?
Q50859489	Combined Angiography and Late Gadolinium Enhancement Acquisition to Improve Assessment of Pulmonary Vein Isolation for Atrial Fibrillation.
Q36935868	Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging
Q36954258	Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease
Q46427856	Comparison between contrast-enhanced magnetic resonance imaging and Selvester QRS scoring system in estimating changes in infarct size between the acute and chronic phases of myocardial infarction.
Q34293824	Comparison of X-ray fluoroscopy and interventional magnetic resonance imaging for the assessment of coronary artery stenoses in swine
Q36922066	Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict recovery of left ventricular function after coronary artery bypass surgery
Q35141223	Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths
Q37278781	Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction
Q47736311	Computational Modeling for Cardiac Resynchronization Therapy.
Q26739767	Computational Representations of Myocardial Infarct Scars and Implications for Arrhythmogenesis
Q36485009	Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy
Q43068784	Connecting the dots: the relevance of scar in nonischemic cardiomyopathy
Q27008874	Contemporary cardiovascular imaging methods for the assessment of at-risk myocardium
Q36457860	Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside
Q35582214	Contrast-Enhanced C-arm Computed Tomography Imaging of Myocardial Infarction in the Interventional Suite
Q53659656	Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.
Q79866790	Contrast-enhanced adenosine-stress magnetic resonance imaging--feasibility and practicability of a protocol for detection or exclusion of ischemic heart disease in an outpatient setting
Q53407613	Contrast-enhanced cardiac MRI before coronary artery bypass surgery: impact of myocardial scar extent on bypass flow.
Q46087490	Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction
Q37074696	Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability
Q52926761	Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing.
Q36247857	Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction
Q30487553	Coronary microvascular resistance: methods for its quantification in humans
Q36588435	Correction with blood T1 is essential when measuring post-contrast myocardial T1 value in patients with acute myocardial infarction
Q83429367	Correlation of left ventricular wall thickness, heart mass, serological parameters and late gadolinium enhancement in cardiovascular magnetic resonance imaging of myocardial inflammation in an experimental animal model of autoimmune myocarditis
Q88828598	Could 82Rb-PET be the next best thing in evaluation of myocardial salvage?
Q36945257	Current and upcoming roles of CT and MRI in clinical cardiac imagery
Q37397537	Dark blood late enhancement imaging.
Q37101410	Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation.
Q49721083	Dark-Blood Delayed Enhancement Cardiac Magnetic Resonance of Myocardial Infarction
Q90484549	Deep Learning for Cardiac Image Segmentation: A Review
Q57823261	Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance
Q53397183	Defining myocardial infarction by cardiac computed tomography.
Q26775739	Delayed Myocardial Enhancement in Cardiac Magnetic Resonance Imaging
Q80368855	Delayed contrast enhancement in a patient with perimyocarditis on contrast-enhanced cardiac MRI: case report
Q53545399	Delayed contrast enhancement magnetic resonance imaging in congenital aortic stenosis.
Q52954584	Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction.
Q36379549	Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedside
Q51568683	Delayed enhancement imaging of myocardial viability: low-dose high-pitch CT versus MRI.
Q34697982	Delayed gadolinium enhancement in the atrial wall: a novel finding in 3 patients with rheumatic heart disease.
Q34457829	Delayed uptake and washout of contrast in non-viable infarcted myocardium shown with dynamic computed tomography
Q79991562	Delayed-contrast enhancement cardioresonance in transient left ventricular apical ballooning
Q30433619	Detecting unrecognized myocardial infarction: the importance of imaging
Q55027735	Detection of Recent Myocardial Infarction Using Native T1 Mapping in a Swine Model: A Validation Study.
Q37424841	Detection of myocardial damage in patients with sarcoidosis
Q35886041	Determination of infarct size in ex vivo swine hearts by multidetector computed tomography using gadolinium as contrast medium
Q33830977	Determination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 T
Q30424619	Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging
Q34222453	Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance
Q38378745	Diagnostic Accuracy of 3.0-T Magnetic Resonance T1 and T2 Mapping and T2-Weighted Dark-Blood Imaging for the Infarct-Related Coronary Artery in Non-ST-Segment Elevation Myocardial Infarction
Q42578602	Diagnostic accuracy of cardiac computed tomography angiography for myocardial infarction
Q50439744	Diagnostic accuracy of late iodine enhancement on cardiac computed tomography with a denoise filter for the evaluation of myocardial infarction
Q36982543	Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy
Q80625542	Diagnostic value of late gadolinium-enhanced MRI and first-pass dynamic MRI for predicting functional recovery in patients after acute myocardial infarction
Q53638516	Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging
Q44649769	Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging. Delayed enhancement and routine clinical parameters after myocardial infarction.
Q51019476	Differences in quantitative assessment of myocardial scar and gray zone by LGE-CMR imaging using established gray zone protocols.
Q40487704	Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR.
Q46927075	Differentiation of transmural and nontransmural infarction using speckle tracking imaging to assess endocardial and epicardial torsion after revascularization
Q61913936	Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis
Q36555925	Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials
Q38973259	Diffusion Tensor Imaging of Healthy and Infarcted Porcine Hearts: Study on the Impact of Formalin Fixation
Q84938192	Direct detection of myocardial fibrosis by MRI
Q33491835	Disappearance of myocardial perfusion defects on prone SPECT imaging: comparison with cardiac magnetic resonance imaging in patients without established coronary artery disease
Q34432749	Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping
Q90667518	Dual-Contrast 19F/1H Magnetic Resonance Imaging to Characterize Myocardial Infarct Healing
Q35018236	Dynamic CT perfusion imaging of the myocardium: a technical note on improvement of image quality
Q34992842	Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index
Q37357765	ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis
Q35936957	Early assessment of myocardial contractility by contrast-enhanced magnetic resonance (ceMRI) imaging after revascularization in acute myocardial infarction (AMI).
Q57679889	Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients
Q80414190	Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia
Q30279182	Effect of Scar Compaction on the Therapeutic Efficacy of Anisotropic Reinforcement Following Myocardial Infarction in the Dog.
Q30408532	Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis
Q30456092	Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography
Q35198568	Effects of high-dose atorvastatin pretreatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a cardiac magnetic resonance study.
Q62246055	Effects of intracoronary melatonin on ischemia–reperfusion injury in ST-elevation myocardial infarction
Q85940571	Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Q89205587	Efficacy of cardiac magnetic resonance for the qualitative diagnosis of blunt cardiac injury
Q37305355	Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy.
Q35549595	Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
Q36676235	Electromechanical analysis of infarct border zone in chronic myocardial infarction
Q38126089	Emerging concepts for myocardial late gadolinium enhancement MRI.
Q34746688	Endogenous assessment of chronic myocardial infarction with T(1ρ)-mapping in patients
Q79370727	Energetic differences between viable and non-viable myocardium in patients with recent myocardial infarction are not an effect of differences in wall thinning- a multivoxel (31)P-MR-spectroscopy and MRI study
Q39864941	Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy
Q51731741	Evaluating the optimal timing of revascularisation in patients with transient ST-segment elevation myocardial infarction: rationale and design of the TRANSIENT Trial.
Q53278215	Evaluation of Modified Look-Locker Inversion Recovery and Arrhythmia-Insensitive Rapid Cardiac T1 Mapping Pulse Sequences in Cardiomyopathy Patients.
Q30486562	Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: an open-access grand challenge
Q51067390	Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance.
Q30372590	Evaluation of myocardial viability in old myocardial infarcted patients with CHF: delayed enhancement MRI vs. low-dose dobutamine stress speckle tracking echocardiography
Q35020200	Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation
Q58450406	Examining a canine model of stunned myocardium with Gd-DTPA-enhanced MRI
Q36248124	Executive Summary of the Guidelines on Stable Coronary Disease
Q35955262	Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology
Q47986863	Fast, three-dimensional free-breathing MR imaging of myocardial infarction: a feasibility study
Q41107826	Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging.
Q47376188	Fibrosis imaging: Current concepts and future directions
Q92132136	Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
Q38556230	First-pass contrast-enhanced myocardial perfusion MRI in mice on a 3-T clinical MR scanner
Q35225864	Free-breathing 3D late gadolinium enhancement imaging of the left ventricle using a stack of spirals at 3T
Q35449845	Free-breathing combined three-dimensional phase sensitive late gadolinium enhancement and T1 mapping for myocardial tissue characterization.
Q33789865	Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients.
Q83229900	Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study
Q85125282	Functional cardiac MR imaging with true fast imaging with steady-state free precession before and after intravenous injection of contrast medium: comparison of image quality and accuracy
Q35632156	Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough
Q42571665	Gadolinium can depict area at risk and myocardial infarction: a double-edged sword?
Q34178860	Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
Q39793429	Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro
Q73383444	Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?
Q38162826	Gated SPECT in assessment of regional and global left ventricular function: an update
Q36437835	Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging
Q46047664	Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement
Q54957156	Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar.
Q36085813	Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy
Q44094868	Head-to-head comparison of a 2-day myocardial perfusion gated SPECT protocol and cardiac magnetic resonance late gadolinium enhancement for the detection of myocardial infarction
Q36285946	Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps.
Q36846765	Highly accelerated cardiovascular MR imaging using many channel technology: concepts and clinical applications.
Q33741738	How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
Q47264846	How to quantify infarct size on delayed-enhancement MR images: a comparison between visual and quantitative approach
Q36951054	Identification and acute targeting of gaps in atrial ablation lesion sets using a real-time magnetic resonance imaging system
Q84395725	Identification and further differentiation of subendocardial and transmural myocardial infarction by fast strain-encoded (SENC) magnetic resonance imaging at 3.0 Tesla
Q41864728	Identification of different heart tissues from MRI C-SENC images using an unsupervised multi-stage fuzzy clustering technique.
Q37248274	Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance
Q33760563	Imaging approaches for the study of cell-based cardiac therapies
Q37371759	Imaging diabetes mellitus with coronary computed tomography angiography, cardiovascular magnetic resonance, and positron emission tomography
Q42850844	Imaging of Subendocardial Myocardial Blood Flow by Dye-Staining Cardioscopy in Patients With Coronary Artery Disease
Q36052795	Imaging of cardiovascular complications in patients with systemic lupus erythematosus.
Q30479851	Imaging of myocardial infarction for diagnosis and intervention using real-time interactive MRI without ECG-gating or breath-holding
Q43960938	Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits
Q30499502	Imaging techniques in cardiac resynchronization therapy
Q43123148	Imaging the area at risk in myocardial infarction with cardiovascular magnetic resonance
Q88105560	Imaging the myocardial ischemic cascade
Q38038533	Imaging the myocardial microcirculation post-myocardial infarction
Q38719247	Imaging-guided Ventricular Tachycardia Ablation
Q58577361	Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation
Q43217779	Impact of contrast material volume on quantitative assessment of reperfused acute myocardial infarction using delayed-enhancement 64-slice CT: experience in a porcine model
Q83469016	Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI
Q31045880	Impact of scar on water-perfusable tissue index in chronic ischemic heart disease: Evaluation with PET and contrast-enhanced MRI.
Q53305314	Impact of tube current in the quantitative assessment of acute reperfused myocardial infarction with 64-slice delayed-enhancement CT: a porcine model.
Q90615379	Improved co-registration of ex-vivo and in-vivo cardiovascular magnetic resonance images using heart-specific flexible 3D printed acrylic scaffold combined with non-rigid registration
Q30559572	Improved fat water separation with water selective inversion pulse for inversion recovery imaging in cardiac MRI.
Q33753521	Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease
Q31042856	In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR.
Q30539291	In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium
Q39014992	Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease
Q26829408	Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the Imaging Working Group of the AEPC and the Cardiovascular Magnetic Resonance Section of the EACVI
Q62075654	Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the Imaging Working Group of the AEPC and the Cardiovascular Magnetic Resonance Section of the EACVI
Q85097591	Indirectly probing Ca2+ handling alterations following myocardial infarction in a murine model using T1‐mapping manganese‐enhanced magnetic resonance imaging
Q37328365	Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia
Q37379908	Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage
Q33644184	Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo
Q36741315	Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction
Q64927306	Influence of Myocardial Hemorrhage on Staging of Reperfused Myocardial Infarctions With T2 Cardiac Magnetic Resonance Imaging: Insights Into the Dependence on Infarction Type With Ex Vivo Validation.
Q35013024	Integrated approach to evaluating coronary artery disease and ischemic heart disease
Q85225888	Integration of MR images with electroanatomical maps: feasibility and utility in guiding left ventricular substrate mapping
Q36186636	Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT
Q30435070	Intracardiac acoustic radiation force impulse (ARFI) and shear wave imaging in pigs with focal infarctions
Q37625636	Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)
Q46192264	Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T.
Q36364317	Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial
Q40260333	Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging
Q36365528	Inversion-recovery single-shot cardiac MRI for the assessment of myocardial infarction at 1.5 T with a dedicated cardiac coil
Q34534779	Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones
Q35845175	Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization?
Q38703283	Is cardiac magnetic resonance necessary for prediction of left ventricular remodeling in patients with reperfused ST-segment elevation myocardial infarction?
Q47639274	Ischemic Mitral Regurgitation: Abnormal Strain Overestimates Non-Viable Myocardium.
Q35582350	Isolated left ventricular apical hypoplasia: a new congenital anomaly described with cardiac tomography
Q37316808	Isolated, broad-based apical diverticulum: cardiac magnetic resonance is a "terminator" of cardiac imaging modality for the evaluation of cardiac apex
Q90668327	Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization
Q91892387	Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography
Q58450389	Late Gadolinium Enhancement Imaging
Q42850935	Late Gadolinium-Enhanced Cardiovascular MRI at End-Systole: Feasibility Study
Q36672304	Late gadolinium enhancement among survivors of sudden cardiac arrest
Q36118129	Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease.
Q81280335	Late gadolinium enhancement in cardiomyopathy
Q43072560	Late gadolinium enhancement in the diagnostics of ischemic heart disease: technical principles, contrast optimization and clinical application
Q53150784	Late gadolinium enhancement magnetic resonance imaging for the assessment of myocardial infarction: comparison of image quality between single and double doses of contrast agents.
Q48148892	Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy?
Q33392473	Late gadolinium uptake demonstrated with magnetic resonance in patients where automated PERFIT analysis of myocardial SPECT suggests irreversible perfusion defect
Q36099925	Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart
Q50001942	Late iodine enhancement computed tomography with image subtraction for assessment of myocardial infarction
Q53005994	Late myocardial enhancement assessed by 64-MSCT in reperfused porcine myocardial infarction: diagnostic accuracy of low-dose CT protocols in comparison with magnetic resonance imaging.
Q53501338	Late-phase MSCT in the different stages of myocardial infarction: animal experiments.
Q53586110	Lateral MI Explains the Presence of Prominent R Wave (R ≥ S) in V1.
Q38382606	Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Q35012228	Left atrial late gadolinium enhancement with water-fat separation: the importance of phase-encoding order
Q37637819	Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia
Q30867239	Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.
Q37250980	Left ventricular infarct size assessed with 0.1 mmol/kg of gadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine
Q33556801	Left ventricular stroke volume quantification by contrast echocardiography - comparison of linear and flow-based methods to cardiac magnetic resonance
Q50137922	Lights on! Can visual light help distinguish fibrotic scars from ablation lesions?
Q90046324	Local Conduction Velocity in the Presence of Late Gadolinium Enhancement and Myocardial Wall Thinning: A Cardiac Magnetic Resonance Study in a Swine Model of Healed Left Ventricular Infarction
Q34636288	Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction
Q33677751	Longitudinal peak strain detects a smaller risk area than visual assessment of wall motion in acute myocardial infarction
Q34481677	MOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements
Q79294238	MR Imaging Evaluation of Myocardial Viability in the Setting of Equivocal SPECT Results with99mTc Sestamibi
Q53340649	MR delayed enhancement imaging findings in suspected acute myocarditis.
Q46946838	MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium
Q44472022	MR imaging of myocardial perfusion and viability
Q30470368	MRI and CT in the diagnosis of coronary artery disease: indications and applications
Q35880029	MRI in coronary artery disease
Q36108746	MRI in guiding and assessing intramyocardial therapy.
Q36760572	MRI versus CT for the detection of coronary artery disease: current state and future promises
Q58805651	MRI with gadofosveset: A potential marker for permeability in myocardial infarction
Q34546508	MRI-3D ultrasound-X-ray image fusion with electromagnetic tracking for transendocardial therapeutic injections: in-vitro validation and in-vivo feasibility
Q30476579	Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.
Q42591569	Magnetic resonance identification of the ventricular tachycardia critical isthmus: finding the needle in the haystack
Q36804563	Magnetic resonance imaging and its role in myocardial regenerative therapy
Q26824231	Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies
Q36949923	Magnetic resonance imaging and radiofrequency ablations
Q48723921	Magnetic resonance imaging early after acute myocardial infarction. A visual analysis of myocardial perfusion based on a 17 segment model
Q37387245	Magnetic resonance imaging findings in apical ballooning syndrome or takotsubo cardiomyopathy
Q84580371	Magnetic resonance imaging goes postmortem: noninvasive detection and assessment of myocardial infarction by postmortem MRI
Q36536238	Magnetic resonance imaging in coronary artery bypass surgery--improvement of global and segmental function in patients with severely compromized left ventricular function
Q35585858	Magnetic resonance imaging in ischemic heart disease
Q36052950	Magnetic resonance imaging in the assessment of coronary artery disease
Q36076780	Magnetic resonance imaging in the diagnostics of myocardial infarction
Q37507438	Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement.
Q37154775	Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back
Q34071911	Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.
Q30475465	Magnetic resonance imaging: a wealth of cardiovascular information
Q33743749	Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation
Q44609211	Magnetic resonance-derived circumferential strain provides a superior and incremental assessment of improvement in contractile function in patients early after ST-segment elevation myocardial infarction
Q53277817	Measuring myocardium at risk in acute myocardial infarction--a continuing challenge.
Q36384512	Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study
Q93099741	Mechanisms of cardiac collagen deposition in experimental models and human disease
Q35149077	Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction
Q59129683	Microvascular dysfunction determines infarct characteristics in patients with reperfused ST-segment elevation myocardial infarction: The MICROcirculation in Acute Myocardial Infarction (MICRO-AMI) study
Q38605332	Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
Q36714047	Midlife Cardiovascular Risk Factors and Late-Life Unrecognized and Recognized Myocardial Infarction Detect by Cardiac Magnetic Resonance: ICELAND-MI, the AGES-Reykjavik Study
Q81924371	Midwall myocardial fibrosis in Becker-Kiener muscular dystrophy
Q33723616	Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation
Q43180096	Mitral valve prolapse: a deeper look
Q37061490	Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping
Q85074755	Molecular imaging: T2-weighted CMR of the area at risk--a risky business?
Q36082326	Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction
Q36676100	Multi-contrast delayed enhancement provides improved contrast between myocardial infarction and blood pool
Q35038983	Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis
Q46408631	Multidetector computed tomography (MDCT) evaluation of myocardial viability: intraindividual comparison of monomeric vs. dimeric contrast media in a rabbit model.
Q46157020	Multidetector-row computed tomographic evaluation of myocardial perfusion in reperfused chronic myocardial infarction: value of color-coded perfusion map in a porcine model
Q88303994	Multimodality Imaging and Clinical Significance of Congenital Ventricular Outpouchings: Recesses, Diverticula, Aneurysms, Clefts, and Crypts
Q36728670	Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?
Q37808653	Multimodality imaging in the assessment of myocardial viability
Q30274835	Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model
Q38378568	Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
Q30451911	Myocardial Salvage Determined by Cardiac Magnetic Resonance Is the Most Important Prognostic Imaging Indicator in Acute Myocardial Infarction
Q36480018	Myocardial T1 mapping at 3.0 tesla using an inversion recovery spoiled gradient echo readout and bloch equation simulation with slice profile correction (BLESSPC) T1 estimation algorithm
Q26996570	Myocardial Tissue Characterization: Histological and Pathophysiological Correlation
Q42244547	Myocardial Viability on Cardiac Magnetic Resonance.
Q85042071	Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging
Q37457781	Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure
Q34554094	Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling
Q43134157	Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
Q30421950	Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation
Q36931178	Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions
Q34686973	Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus
Q39572402	Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
Q34629550	Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
Q46846924	Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis
Q36673817	Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem
Q37187048	Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization.
Q88035087	Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance
Q43087306	Myocardial perfusion magnetic resonance imaging for detecting coronary function anomalies in asymptomatic paediatric patients with a previous arterial switch operation for the transposition of great arteries
Q79759787	Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart
Q44764199	Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up.
Q45754126	Myocardial scar identification based on analysis of Look-Locker and 3D late gadolinium enhanced MRI.
Q78726625	Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
Q36164284	Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy
Q35772538	Myocardial scars determined by delayed-enhancement magnetic resonance imaging and positron emission tomography are not common in right ventricles with systemic function in long-term follow up
Q46316701	Myocardial strain in sub-acute peri-infarct myocardium
Q36636983	Myocardial structural associations with local electrograms: a study of postinfarct ventricular tachycardia pathophysiology and magnetic resonance-based noninvasive mapping
Q27025677	Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping
Q53643024	Myocardial viability assessment by contrast-enhanced magnetic resonance imaging.
Q45309552	Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization
Q37766159	Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches
Q44411140	Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography
Q45393899	Myocardium at risk: reasons and methods for measuring the extent
Q48155889	Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed
Q57791708	Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique
Q28972564	Nephrogenic systemic fibrosis: a concise review for cardiologists
Q28083928	New Imaging Technologies To Characterize Arrhythmic Substrate
Q51476311	New automated Markov-Gibbs random field based framework for myocardial wall viability quantification on agent enhanced cardiac magnetic resonance images.
Q37007953	New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop
Q36185831	Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification
Q34544821	Non-contrast cardiac computed tomography can accurately detect chronic myocardial infarction: Validation study
Q90628326	Non-contrast myocardial infarct scar assessment using a hybrid native T1 and magnetization transfer imaging sequence at 1.5T
Q64053668	Non-infarcted myocardium bears the weight in CVD
Q83048001	Non-invasive cardiac evaluation in heart failure patients using magnetic resonance imaging: a feasibility study
Q40964405	Non-invasive imaging in detecting myocardial viability: Myocardial function versus perfusion
Q34774619	Noninvasive assessment myocardial viability: current status and future directions
Q39520386	Noninvasive assessment of myocardial viability in a small animal model: comparison of MRI, SPECT, and PET.
Q30481557	Noninvasive cardiovascular imaging techniques for basic science research: application to cellular therapeutics
Q36283010	Noninvasive electrocardiographic imaging of chronic myocardial infarct scar
Q73882036	Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction
Q53575622	Novel application of 3D contrast-enhanced CMR to define fibrotic structure of the human sinoatrial node in vivo.
Q37578330	Nuclear cardiology and heart failure
Q42015792	Optical projection tomography permits efficient assessment of infarct volume in the murine heart postmyocardial infarction
Q57172175	Optimal site selection and image fusion guidance technology to facilitate cardiac resynchronization therapy
Q44301088	Optimization of myocardial nulling in pediatric cardiac MRI.
Q46091082	P846, a new gadolinium based low diffusion magnetic resonance contrast agent, in characterizing occlusive infarcts, reperfused ischemic myocardium and reperfused infarcts in rats
Q37357099	PET and MRI in cardiac imaging: from validation studies to integrated applications
Q42682259	PROMETHEUS and POSEIDON: Harnessing the power of advanced cardiac imaging
Q36480787	Parallel imaging in cardiovascular MRI: methods and applications
Q30815396	Pathological mechanism for delayed hyperenhancement of chronic scarred myocardium in contrast agent enhanced magnetic resonance imaging
Q36304697	Patients with exercise-associated ventricular ectopy present evidence of myocarditis
Q33895261	Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.
Q41920674	Percent infarct mapping for delayed contrast enhancement magnetic resonance imaging to quantify myocardial viability by Gd(DTPA).
Q35149965	Performing cardiac MR imaging: an overview
Q46580574	Perfusion weighted color maps for enhanced visualization of myocardial infarction by MSCT: preliminary experience
Q93083886	Peri-procedural myocardial infarction is all the same?
Q65000769	Personalized Cardiac Computational Models: From Clinical Data to Simulation of Infarct-Related Ventricular Tachycardia.
Q38227381	Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review.
Q36092047	Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.
Q26849357	Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI
Q80097764	Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy
Q30352821	Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent.
Q57760906	Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
Q31095579	Pre to Intraoperative Data Fusion Framework for Multimodal Characterization of Myocardial Scar Tissue.
Q80695335	Pre- and post-synaptic sympathetic function in human hibernating myocardium
Q34304041	Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance
Q35722052	Predictors and prognostic value of left atrial remodelling after acute myocardial infarction.
Q37497985	Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
Q30432693	Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy
Q93177346	Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults
Q34065646	Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults
Q39333600	Prevalence of different forms of infarct-atypical late gadolinium enhancement in patients early and late after heart transplantation
Q30473748	Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study
Q28082235	Principles and techniques of imaging in identifying the substrate of ventricular arrhythmia
Q36760564	Prognosis following acute myocardial infarction: insights from cardiovascular magnetic resonance
Q36477873	Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
Q37549439	Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension
Q47106346	Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar.
Q24653881	Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals
Q33773350	Pulmonary arterial hypertension: use of delayed contrast-enhanced cardiovascular magnetic resonance in risk assessment
Q37682454	Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT.
Q37613056	Q wave area for stratification of global left ventricular infarct size: comparison to conventional ECG assessment using Selvester QRS-score
Q37670689	Quantification in cardiac MRI: advances in image acquisition and processing
Q35090442	Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping
Q38373237	Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores
Q47302700	Quantitation of infarct size in patients with chronic coronary artery disease using rest-redistribution Tl-201 myocardial perfusion SPECT: correlation with contrast-enhanced cardiac magnetic resonance
Q35090854	Quantitative Assessment of Single-Image Super-Resolution in Myocardial Scar Imaging.
Q35555913	Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators
Q36113656	Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation
Q59548918	Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring
Q37239711	Quantitative evaluation of the amount of delayed myocardial enhancement as a predictor of systolic dysfunction
Q33587892	Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art
Q52732896	Radiation dose management for pediatric cardiac computed tomography: a report from the Image Gently 'Have-A-Heart' campaign.
Q33361149	Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone
Q33660936	Rapid T1 quantification based on 3D phase sensitive inversion recovery
Q47193321	Rapid and accurate determination of relative infarct size in humans using contrast-enhanced magnetic resonance imaging
Q38591015	Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T.
Q33327561	Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size
Q35084600	Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial
Q43046322	Rationale of the REPARATOR study: A randomised trial with serial cardiac MRI follow-up testing the ability of atorvastatin to reduce reperfusion damage after primary PCI for acute MI.
Q30756526	Real-Time MRI-Guided Cardiac Cryo-Ablation: A Feasibility Study
Q65002059	Recent Advances in Cardiac Magnetic Resonance Imaging.
Q38829878	Recent Advances in Nuclear Cardiology
Q37244354	Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study
Q35635501	Reduction of QTD--A Novel Marker of Successful Reperfusion in NSTEMI. Pathophysiologic Insights by CMR
Q51407125	Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study.
Q34743695	Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study
Q41001981	Relation of the ischaemic substrate to left ventricular remodelling by cardiac magnetic resonance at 1.5 T in rabbits
Q47327553	Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging
Q37599602	Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial
Q33746375	Relationship between intended sites of RF ablation and post-procedural scar in AF patients, using late gadolinium enhancement cardiovascular magnetic resonance
Q35854853	Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk
Q73782480	Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease
Q92288947	Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes
Q57448705	Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction
Q40625539	Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality
Q35954778	Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs
Q35023264	Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia
Q34778776	Risk stratification of non-contrast CT beyond the coronary calcium scan
Q51876709	Robust assessment of the transmural extent of myocardial infarction in late gadolinium-enhanced MRI studies using appropriate angular and circumferential subdivision of the myocardium.
Q30279246	Role of Cardiac MR Imaging in Cardiomyopathies
Q26829719	Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance.
Q35818918	Role of MRI in clinical cardiology
Q47397915	Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI.
Q37662894	Role of cardiac MRI in diabetes
Q54237905	Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction.
Q30573820	Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis
Q49526018	Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease
Q33812907	Role of cardiovascular magnetic resonance in assessment of acute coronary syndrome
Q48003421	Role of first pass and delayed enhancement in assessment of segmental functional recovery after acute myocardial infarction
Q51297181	Salvage assessment with cardiac MRI following acute myocardial infarction underestimates potential for recovery of systolic strain.
Q92241667	Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
Q36722619	Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease
Q37114057	Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.
Q37108215	Scar quantification by cardiovascular magnetic resonance as an independent predictor of long-term survival in patients with ischemic heart failure treated by coronary artery bypass graft surgery
Q51969229	Segmentation of non-viable myocardium in delayed enhancement magnetic resonance images.
Q60302167	Selective infarct zone imaging with intravenous acoustically activated droplets
Q33822332	Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy
Q34101269	Simultaneous myocardial strain and dark-blood perfusion imaging using a displacement-encoded MRI pulse sequence
Q53070131	Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI.
Q57799812	Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI
Q41361568	Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories
Q30479223	Staged cardiovascular magnetic resonance for differential diagnosis of Troponin T positive patients with low likelihood for acute coronary syndrome
Q50058883	Standard Ablation Versus Magnetic Resonance Imaging-Guided Ablation in the Treatment of Ventricular Tachycardia
Q74033471	Subacute myocardial infarction: assessment by STIR T2-weighted MR imaging in comparison to regional function
Q39388903	Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications
Q30433543	Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop
Q80302786	Surgical ventricular restoration based on evaluation of myocardial viability with delayed-enhanced magnetic resonance imaging
Q35379399	Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging.
Q53798523	T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
Q37160724	T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
Q41825364	T1-weighted cine FLASH is superior to IR imaging of post-infarction myocardial viability at 4.7T.
Q41299379	Tachycardia in post-infarction hearts: insights from 3D image-based ventricular models.
Q36301149	Technology insight: MRI of the myocardium
Q36304287	Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging
Q30441655	Technology insight: in vivo cell tracking by use of MRI.
Q28741811	The Cardiac Atlas Project--an imaging database for computational modeling and statistical atlases of the heart
Q87659738	The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure
Q35789203	The Role of Cardiac MRI in Patients with Troponin-Positive Chest Pain and Unobstructed Coronary Arteries.
Q92968040	The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
Q26744817	The Role of Imaging in Aortic Valve Disease
Q26745987	The Use of Cardiac Magnetic Resonance in Patients with Suspected Coronary Artery Disease: A Clinical Practice Perspective
Q27014679	The cardiac magnetic resonance (CMR) approach to assessing myocardial viability
Q37766179	The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy
Q84478810	The diagnostic utility of cardiovascular magnetic resonance in patients with chest pain, elevated cardiac enzymes and non-obstructed coronary arteries
Q30475257	The emerging clinical role of cardiovascular magnetic resonance imaging
Q36409266	The emerging role of MRI in the diagnosis and management of cardiomyopathies
Q38129262	The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease
Q30410606	The feasibility of myocardial infarct visualization using atrial kick induced strain (AKIS) contrast
Q47394429	The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study
Q30424130	The microvasculature after reperfused myocardial infarction: to examine or not to examine?
Q35150699	The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques
Q40722200	The number of unrecognized myocardial infarction scars detected at DE-MRI increases during a 5-year follow-up
Q38068352	The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies
Q37852590	The role of cardiac MR in new-onset heart failure
Q37996927	The role of cardiac magnetic resonance imaging following acute myocardial infarction
Q33999939	The role of cardiovascular magnetic resonance in heart failure
Q37139952	The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations
Q30426380	The role of magnetic resonance imaging in hypertrophic cardiomyopathy
Q38747232	The role of myocardial viability in contemporary cardiac practice
Q38132711	The role of radionuclide imaging in heart failure
Q89415796	The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
Q37738257	The use of cardiovascular magnetic resonance in acute myocardial infarction
Q53090086	The usefulness of delayed contrast-enhanced cardiovascular magnetic resonance imaging in differentiating cardiac tumors from thrombi in stroke patients.
Q36859243	Three dimensional fusion of electromechanical mapping and magnetic resonance imaging for real-time navigation of intramyocardial cell injections in a porcine model of chronic myocardial infarction
Q28084180	Three-dimensional cardiac computational modelling: methods, features and applications
Q57182056	Three-dimensional holographic visualization of high-resolution myocardial scar on HoloLens
Q48601081	Three-dimensional maximum principal strain using cardiac computed tomography for identification of myocardial infarction
Q35032527	Three-dimensional phase-sensitive inversion-recovery Turbo FLASH sequence for the assessment of left ventricular myocardial scar in swine
Q43825991	Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability: a feasibility study
Q35666931	Time elapsed after contrast injection is crucial to determine infarct transmurality and myocardial functional recovery after an acute myocardial infarction
Q92638131	Time-Dependent Myocardial Necrosis in Patients With ST-Segment-Elevation Myocardial Infarction Without Angiographic Collateral Flow Visualized by Cardiac Magnetic Resonance Imaging: Results From the Multicenter STEMI-SCAR Project
Q35249522	Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling
Q27003231	Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging
Q30778784	Tissue-specific MR contrast agents
Q37717680	Tools for cardiovascular magnetic resonance imaging
Q84567556	Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography
Q30444785	Towards stratifying ischemic components by cardiac MRI and multifunctional stainings in a rabbit model of myocardial infarction
Q30787159	Transcatheter Myocardial Needle Chemoablation During Real-Time Magnetic Resonance Imaging: A New Approach to Ablation Therapy for Rhythm Disorders.
Q33704554	Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model
Q36172904	Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction
Q35089452	TrueFISP--technical considerations and cardiovascular applications
Q30423185	T₂ -weighted MRI of post-infarct myocardial edema in mice
Q33432746	Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease
Q45944727	Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.
Q35989654	Use of cardiac magnetic resonance to assess viability
Q37314823	Use of cardiovascular magnetic resonance imaging in acute coronary syndromes
Q37427557	Usefulness of Q-wave area for threshold-based stratification of global left ventricular myocardial infarct size
Q41386852	Usefulness of multidetector-row CT in the evaluation of reperfused myocardial infarction in a rabbit model
Q30479106	Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling
Q36462622	Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction
Q36606044	Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis
Q95260617	Validation of black blood late gadolinium enhancement (LGE) for evaluation of myocardial infarction in patients with or without pathological Q-wave on electrocardiogram (ECG)
Q30570123	Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction
Q53161470	Ventricular muscarinic receptor remodeling in patients with and without primary ventricular fibrillation. An imaging study.
Q40014186	Ventricular tachycardia as the first manifestation of cardiac sarcoidosis
Q36081641	Viability assessment after conventional coronary angiography using a novel cardiovascular interventional therapeutic CT system: Comparison with gross morphology in a subacute infarct swine model.
Q39612848	Virtual electrophysiological study in a 3-dimensional cardiac magnetic resonance imaging model of porcine myocardial infarction.
Q53609367	Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI.
Q31988500	Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction
Q52888555	Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients.
Q88629390	Wideband LGE MRI permits unobstructed viewing of myocardial scarring in a patient with an MR-conditional subcutaneous implantable cardioverter-defibrillator
Q35152757	Wideband late gadolinium enhanced magnetic resonance imaging for imaging myocardial scar without image artefacts induced by implantable cardioverter-defibrillator: a feasibility study at 3 T
Q92754511	Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis
Q82276535	["Integrated care"--the Essen concept: organizational strategies in the treatment of acute myocardial infarction]
Q84015604	[Cardiac diffusion imaging: toward new insights in myocardial ischemia]
Q83551949	[Interventional electrophysiology in cardiac MRI : what is the current status?]
Q80914157	[Ischemic heart disease (myocardial perfusion and viability): techniques and results]
Q86821081	[Prognostic value of cardiovascular MRI in diabetics]
Q80577070	[Reliability of cardiac magnetic resonance imaging indicators of myocardial viability for predicting the recovery of systolic function after a first acute myocardial infarction with a patent culprit artery]
Q85378191	[Use of cardiac MRI in the field of electrophysiology. Present status and future aspects]

P356	DOI	10.1161/01.CIR.100.19.1992
P698	PubMed publication ID	10556226

P50	author	Todd B Parrish	Q88341640
P2093	author name string	Harris K
		Judd RM
		Kim RJ
		Finn JP
		Parrish TB
		Klocke FJ
		Simonetti O
		Fieno DS
		Bundy J
		Chen EL
P433	issue	19
P407	language of work or name	English	Q1860
P921	main subject	magnetic resonance imaging	Q161238
P304	page(s)	1992-2002
P577	publication date	1999-11-01
P1433	published in	Circulation	Q578091
P1476	title	Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
P478	volume	100

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

scientific article published on 01 November 1999

Reverse relations